Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$0.18 - $0.52 $1,666 - $4,813
9,257 New
9,257 $1,000
Q4 2022

Feb 08, 2023

BUY
$0.35 - $20.75 $3,202 - $189,841
9,149 Added 94.68%
18,812 $7,000
Q3 2022

Nov 10, 2022

BUY
$0.83 - $21.25 $6,183 - $158,312
7,450 Added 336.65%
9,663 $6,000
Q2 2022

Aug 10, 2022

BUY
$1.12 - $2.18 $2,478 - $4,824
2,213 New
2,213 $3,000
Q1 2022

May 16, 2022

SELL
$1.63 - $3.63 $27,845 - $62,011
-17,083 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$2.25 - $4.11 $31,923 - $58,312
14,188 Added 490.09%
17,083 $38,000
Q3 2021

Nov 15, 2021

BUY
$2.71 - $5.9 $1,504 - $3,274
555 Added 23.72%
2,895 $12,000
Q2 2021

Aug 13, 2021

BUY
$4.83 - $9.67 $1,072 - $2,146
222 Added 10.48%
2,340 $12,000
Q1 2021

May 12, 2021

BUY
$6.01 - $8.9 $12,729 - $18,850
2,118 New
2,118 $14,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.